Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neuropathol Appl Neurobiol ; 46(5): 431-440, 2020 08.
Article in English | MEDLINE | ID: mdl-31872472

ABSTRACT

AIMS: We investigated the potential of apolipoprotein D (apoD) as cerebrospinal fluid (CSF) biomarker for cerebral amyloid angiopathy (CAA) after confirmation of its association with CAA pathology in human brain tissue. METHODS: The association of apoD with CAA pathology was analysed in human occipital lobe tissue of CAA (n = 9), Alzheimer's disease (AD) (n = 11) and healthy control cases (n = 11). ApoD levels were quantified in an age- and sex-matched CSF cohort of CAA patients (n = 31), AD patients (n = 27) and non-neurological controls (n = 67). The effects of confounding factors (age, sex, serum levels) on apoD levels were studied using CSF of non-neurological controls (age range 16-85 years), and paired CSF and serum samples. RESULTS: ApoD was strongly associated with amyloid deposits in vessels, but not with parenchymal plaques in human brain tissue. CSF apoD levels correlated with age and were higher in men than women in subjects >50 years. The apoD CSF/serum ratio correlated with the albumin ratio. When controlling for confounding factors, CSF apoD levels were significantly lower in CAA patients compared with controls and compared with AD patients (P = 0.0008). CONCLUSIONS: Our data show that apoD is specifically associated with CAA pathology and may be a CSF biomarker for CAA, but clinical application is complicated due to dependency on age, sex and blood-CSF barrier integrity. Well-controlled follow-up studies are required to determine whether apoD can be used as reliable biomarker for CAA.


Subject(s)
Apolipoproteins D/metabolism , Biomarkers/cerebrospinal fluid , Cerebral Amyloid Angiopathy/pathology , Aged , Cerebral Amyloid Angiopathy/metabolism , Female , Humans , Male , Middle Aged
2.
Eur Urol ; 48(6): 922-30; discussion 930-1, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16263208

ABSTRACT

OBJECTIVES: Epidemiological studies have shown significant relationships between the use of dietary components and prostate cancer incidence and mortality. Large studies of primary prevention, which confirm these findings, are desirable but costly and difficult to design. The present tertiary prevention study reports on the effect of a dietary supplement in comparison with placebo on the rate of increase of prostate-specific antigen (PSA). METHODS: 49 patients with a history of prostate cancer and rising PSA levels after radical prostatectomy (n = 34) or radiotherapy (n = 15) participated in a randomised, double-blind, placebo-controlled crossover study of a dietary supplement. Ethical approval of the protocol was obtained. Treatment periods of 10 weeks were separated by a 4-week washout period. The supplement consisted of soy, isoflavones, lycopene, silymarin and antioxidants as main ingredients. Changes in the rate of increase of PSA (PSA slope and doubling time) were the primary parameters of efficacy. Analyses according to intention to treat (ITT) and per protocol (PP) were carried out. RESULTS: Baseline parameters did not differ between randomised groups. Five participants were lost to follow-up, however 46 could be evaluated in an ITT analysis. PP analysis could be performed in 42 men with at least 5 PSA measurements. Per protocol analysis showed a significant decrease in PSA slope (p = 0.030) and (2)log PSA slope (p = 0.041). This translates into a 2.6 fold increase in the PSA doubling time from 445 to 1150 days for the supplement and placebo periods. No treatment-based changes in safety parameters were observed during the study. CONCLUSIONS: The soy-based dietary supplement utilised in this study was shown to delay PSA progression after potentially curative treatment in a significant fashion. More extensive studies of the supplement may be indicated.


Subject(s)
Biomarkers, Tumor/blood , Dietary Supplements , Neoplasm Recurrence, Local/prevention & control , Prostate-Specific Antigen/blood , Prostatic Neoplasms/pathology , Adult , Age Distribution , Aged , Brachytherapy/methods , Cross-Over Studies , Disease Progression , Double-Blind Method , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Neoplasm Recurrence, Local/diet therapy , Neoplasm Recurrence, Local/epidemiology , Neoplasm Staging , Probability , Prostatectomy/methods , Prostatic Neoplasms/mortality , Prostatic Neoplasms/radiotherapy , Prostatic Neoplasms/surgery , Reference Values , Risk Assessment , Survival Rate , Treatment Outcome
3.
J Glaucoma ; 10(2): 85-8, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11316101

ABSTRACT

PURPOSE: To determine whether hypotony after filtration surgery has any influence on visual acuity and intraocular pressure (IOP) lowering. PATIENTS AND METHODS: We prospectively investigated 43 eyes of 43 patients undergoing trabeculectomy without the use of antimetabolites for 12 months. RESULTS: The lowest postoperative IOP valued 4.9 +/- 3.6 mm Hg (range, 0-14 mm Hg). It correlated statistically significant with the IOP 6 weeks (P = 0.016), 6 months (P = 0.009), and 1 year after surgery (P = 0.027). Eyes with a deterioration of visual acuity 6 weeks after surgery had undergone a stronger postoperative hypotony (correlation with lowest postoperative IOP, P = 0.035). The mean period with an IOP less than 5 mm Hg was 3.5 +/- 8.0 days, and the mean period with an IOP less than 10 mm Hg lasted 45.4 +/- 68.8 days (range, 0-276 days). A hypotony score based on IOP and duration of hypotony was introduced. A correlation was detected between morphologic signs of hypotony, such as tiny retinal folds, at the 6-month follow-up and the duration of hypotony (P = 0.029) and hypotony score (P = 0.001). CONCLUSIONS: Hypotony after filtration surgery may decrease visual acuity in the early postoperative period. Conversely, early postoperative hypotony correlated with better long term IOP control. There was no deleterious effect on visual acuity after 6 months.


Subject(s)
Intraocular Pressure , Ocular Hypotension/physiopathology , Trabeculectomy/adverse effects , Visual Acuity , Adult , Choroid Diseases/diagnosis , Choroid Diseases/etiology , Fundus Oculi , Glaucoma, Open-Angle/surgery , Humans , Intraocular Pressure/physiology , Ocular Hypotension/etiology , Papilledema/diagnosis , Papilledema/etiology , Prospective Studies , Retinal Diseases/diagnosis , Retinal Diseases/etiology , Treatment Outcome , Visual Acuity/physiology
4.
Ophthalmic Res ; 31(2): 127-9, 1999.
Article in English | MEDLINE | ID: mdl-9933774

ABSTRACT

The position of the artificial lens has an important influence on refractive power calculation. We compared the position of the crystalline lens with that of the artificial lens after cataract surgery by means of Scheimpflug photography. A difference in position of approximately 0.8 mm in the anterior direction could be determined.


Subject(s)
Lens, Crystalline/anatomy & histology , Lenses, Intraocular , Photography/methods , Preoperative Care/methods , Prosthesis Fitting , Cataract Extraction , Humans , Lens Implantation, Intraocular , Postoperative Period
5.
Zentralbl Gynakol ; 110(17): 1053-8, 1988.
Article in German | MEDLINE | ID: mdl-3176744

ABSTRACT

198 tissue samples from over all 336 chorionic biopsies obtained by different techniques had been examined histologically. Decidual residues could be found in 37 per cent of the specimens in spite of a twofold estimation of vitality. In correlation our increasing experience the frequency of decidual contamination decreased from 60 to 17 per cent. At the end of our examinations in only 5 per cent of 1,998 microscopic visual fields decidua could be found. This decidual contamination may be reason for misinterpretation of results. This error of the method has to be taken into consideration in all prenatal diagnostic statements especially in DNA- and enzymatic diagnostics.


Subject(s)
Chorion/anatomy & histology , Genetic Markers , Prenatal Diagnosis/methods , Biopsy , Biopsy, Needle , Chromosome Mapping , Decidua/cytology , Female , Humans , Pregnancy , Trophoblasts/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...